News

DICV has introduced two new BharatBenz HX models (2828C HX and 3532C HX) with 280 hp or 320 hp powertrains, advanced driver aids, and high-gradea ...
Fresenius Kabi has licensed rights from Polpharma Biologics to commercialize the vedolizumab biosimilar candidate PB016 globally—except in the ...